Aquilion system offers industry’s largest bore and widest field-of-view, potentially augmenting radiation therapy planning.
Canon Medical Systems received clearance from the U.S. Food & Drug Administration (FDA) Thursday for its Aquilion™ Exceed LB CT system that is designed to improve the planning and delivery of radiation therapy.
As an artificial intelligence-powered system, company officials said, Aquilion is intended to facilitate workflow while maintaining image quality and reproducibility.
Aquilion Exceed LB CT system. Credit: Canon Medical Systems USA, Inc.
“The Aquilion Exceed LB was designed to push the boundaries of traditional simulation,” said Erin Angel, CT business unit managing director for Canon Medical. “Deep learning reconstruction will give radiation oncology teams the confidence they need for accurate and precise planning across patients.”
Based on company details, Aquilion offers several benefits:
CT Study: AI Algorithm Comparable to Radiologists in Differentiating Small Renal Masses
May 14th 2024An emerging deep learning algorithm had a lower AUC and sensitivity than urological radiologists for differentiating between small renal masses on computed tomography (CT) scans but had a 21 percent higher sensitivity rate than non-urological radiologists, according to new research.
Appealing Prior Authorization Denials: Can it be Effective for Emerging Technologies?
May 14th 2024While radiologists and other providers may be discouraged by insurer denials saying the use of a technological advance is “unproven and investigational,” 82 percent of appeals for prior authorization denials were approved in 2021.
What a New Meta-Analysis Reveals About Fractional Flow Reserve Assessment with Computed Tomography
May 13th 2024While acknowledging variable accuracy overall with CT-derived fractional flow reserve (FFR-CT) values, researchers found that the accuracy rate increased to 90 percent for FFR-CT values greater > 0.90 and < 0.49.